SCHEMBL7338227

SCHEMBL7338227

ICC1c2ccccc2Oc2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
ATM Q13315 2/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 1/20 0.43
USP2 O75604 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29737271 0.77 MAOA (0.52) MAOAMAOBATMMEN1KMT2A
SCHEMBL1077580 0.77 MAOA (0.52) MAOAMAOBATMMEN1KMT2A
SCHEMBL31622921 0.77 MAOA (0.52) MAOAMAOBATMMEN1KMT2A
SCHEMBL2736396 0.77 MAOA (0.52) MAOAMAOBATMMEN1KMT2A
SCHEMBL1323794 0.77 MAOA (0.52) MAOAMAOBATMMEN1KMT2A
SCHEMBL4667689 0.77 HTR2A (0.58) MAOAMAOBATMMEN1KMT2A
SCHEMBL7452862 0.77 MAOA (0.52) MAOAMAOBATMMEN1KMT2A
SCHEMBL31410667 0.77 MAOA (0.58) MAOAMAOBATMMEN1KMT2A
SCHEMBL8820720 0.77 MAOA (0.58) MAOAMAOBATMMEN1KMT2A
SCHEMBL30607016 0.77 MAOA (0.52) MAOAMAOBATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2707776-B1 POSITIVE RESIST COMPOSITION, AND RESIST FILM, RESIST-COATED MASK BLANK AND RESIST PATTERN FORMING METHOD EACH USING THE COMPOSITION FUJIFILM CORP (JP) 2017-07-19 EP disclosed
US-6054448-A TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM. ELI LILLY AND COMPANY LIMITED (GB) 2000-04-25 US disclosed
EP-0771196-B1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1999-12-08 EP disclosed
US-5891899-A Pharmaceutical xanthene compounds ELI LILLY AND COMPANY LIMITED (GB) 1999-04-06 US disclosed
EP-0849263-A2 Pharmaceutical substituted propanoic acid derivatives ELI LILLY AND COMPANY LIMITED (GB) 1998-06-24 EP disclosed
EP-0837061-A1 Pharmaceutical acidic compounds ELI LILLY AND COMPANY LIMITED (GB) 1998-04-22 EP disclosed
US-5717109-A CARBOXYCYCLOPROPYL GLYCINE DERIVATIVES; USEFUL FOR TREATMENT OF ACUTE OR CHRONIC NEURODEGENERATIVE CONDITIONS, AND AS ANTIPSYCHOTIC, ANTICONVULSANT, ANALGESIC, ANXIOLYTIC, ANTIDEPRESSANT AND ANTI-EMETIC AGENTS ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
EP-0771196-A4 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1997-09-03 EP disclosed
EP-0771196-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-05-07 EP disclosed
WO-1996007405-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1996-03-14 WO disclosed